CVS Health Corporation $CVS Holdings Increased by RNC Capital Management LLC

Key Points

• RNC Capital Management raised its stake in CVS by 1.6% to 815,930 shares (about $64.8M), while other large managers including Wellington, Amundi and Capital Research made sizable additions, leaving institutional investors with roughly 80.66% ownership.
• Analysts maintain a consensus Moderate Buy rating on CVS (20 Buys, 3 Holds) with an average price target of $95.05.
• CVS beat quarterly estimates (EPS $1.09 vs $1.00; revenue $105.69B, +8.2% YoY) and paid a quarterly dividend of $0.665 (3.2% yield), though the payout ratio is notably high at 192.75%.

RNC Capital Management LLC raised its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 1.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 815,930 shares of the pharmacy operator's stock after buying an additional 12,790 shares during the period. CVS Health comprises about 2.9% of RNC Capital Management LLC's investment portfolio, making the stock its 7th biggest position. RNC Capital Management LLC owned 0.06% of CVS Health worth $64,752,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Wellington Management Group LLP boosted its stake in shares of CVS Health by 391.6% in the 3rd quarter. Wellington Management Group LLP now owns 6,330,717 shares of the pharmacy operator's stock valued at $477,273,000 after purchasing an additional 5,042,816 shares in the last quarter. Amundi boosted its stake in shares of CVS Health by 95.3% in the 3rd quarter. Amundi now owns 7,453,980 shares of the pharmacy operator's stock valued at $572,665,000 after purchasing an additional 3,637,943 shares in the last quarter. Capital Research Global Investors boosted its position in CVS Health by 24.5% during the 3rd quarter. Capital Research Global Investors now owns 11,469,250 shares of the pharmacy operator's stock valued at $864,667,000 after buying an additional 2,253,531 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in CVS Health by 70.5% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 5,294,134 shares of the pharmacy operator's stock valued at $399,125,000 after buying an additional 2,188,307 shares during the period. Finally, Hamlin Capital Management LLC purchased a new stake in CVS Health during the 4th quarter valued at $160,844,000. Institutional investors own 80.66% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Leerink Partners reaffirmed an "outperform" rating and issued a $98.00 target price on shares of CVS Health in a research report on Thursday, March 5th. Robert W. Baird raised their target price on shares of CVS Health from $92.00 to $94.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 15th. Piper Sandler dropped their target price on shares of CVS Health from $101.00 to $99.00 and set an "overweight" rating for the company in a research report on Tuesday, March 31st. Bank of America dropped their target price on shares of CVS Health from $100.00 to $95.00 and set a "buy" rating for the company in a research report on Tuesday, January 27th. Finally, Argus dropped their target price on shares of CVS Health from $91.00 to $90.00 and set a "buy" rating for the company in a research report on Wednesday, January 28th. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $95.05.

CVS Health Stock Performance

CVS opened at $82.06 on Tuesday. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The company has a market cap of $105.17 billion, a price-to-earnings ratio of 59.47, a PEG ratio of 0.86 and a beta of 0.60. The company's 50 day moving average is $76.32 and its 200 day moving average is $77.96. CVS Health Corporation has a 12-month low of $58.35 and a 12-month high of $85.15.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same quarter in the previous year, the firm earned $1.19 earnings per share. The company's revenue for the quarter was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, equities research analysts predict that CVS Health Corporation will post 7.14 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, April 23rd. This represents a $2.66 annualized dividend and a yield of 3.2%. CVS Health's payout ratio is currently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.